
Few events in recent history have forced clinicians and researchers to rethink mental health quite like COVID-19. In this commentary, we reflect on something that struck us while reading the work of Cantone et al. : the pandemic, for all its devastation, created a kind of unplanned observational window, a chance to study, at population scale, what happens when stress and rhythm disruption hit at the same time. Healthcare Workers (HCWs) were at the epicentre of this. They didn't just witness the crisis; they absorbed it, shift after shift, for months. What the data show is that their depressive symptoms and rhythm instability were not random; they appear systematically linked, and at levels one would more typically associate with mood disorder research. We discuss these findings through the lens of DYMERS (Dysregulation of Mood, Energy, and Social Rhythms Syndrome), a heuristic transdiagnostic construct that, in our view, captures something that standard categorical diagnoses tend to miss: the subthreshold, fluctuating psychopathology that sits just below the threshold of formal diagnosis but causes real impairment. The pandemic may not have created these vulnerabilities, but it may well have sharpened our ability to see them.
Introduction/Objective Depression is a disabling mental health disorder affecting over 300 million people worldwide. In Tunisia, population-level data on its prevalence and determinants remain limited. Our study aimed to estimate the prevalence of depression in the Tunisian population and identify associated socio-demographic and clinical factors. Methods Data were drawn from the mental health component of the Tunisian Health Examination Survey (2016), a nationally representative study conducted among 9,209 individuals aged ≥15 years. Self-reported, physician-diagnosed lifetime depression was the main outcome. Associations with socio-demographic characteristics and clinical conditions, including rheumatoid arthritis, diabetes, and menopause, were examined. Results The study population comprised 4360 men (49.2%) and 4849 women (51.8%), with a mean age of 41.4±17.4 years. The prevalence of self-reported lifetime depression was 4.7%. Multivariate analysis identified female sex (OR=1.53, 95% CI [1.11–2.10]) and age groups 30–64 years (OR=1.81, 95% CI [1.20–2.73]) and ≥65 years (OR=1.82, 95% CI [1.06–3.14]) as factors significantly associated with higher prevalence. Conversely, marriage (OR=0.59, 95% CI [0.42–0.84]) and the absence of rheumatoid arthritis (OR=0.48, 95% CI [0.38–0.60]) were associated with a lower prevalence of the disorder. Discussion The findings indicate that self-reported depression in Tunisia is significantly influenced by gender and aging, consistent with global epidemiological trends. The strong association with physical comorbidities, particularly rheumatoid arthritis, underscores the necessity of integrated mental health screening for patients with chronic illnesses. Furthermore, the protective association of marriage suggests that social and family cohesion remain vital factors in the Tunisian sociocultural context. Conclusion Depression in Tunisia is shaped by gender, aging, and physical comorbidities. Targeted prevention and integrated screening strategies are needed, especially for vulnerable demographic and clinical groups.
Franco Basaglia's centenary, celebrated on March 11, 2024, invites reflection on the historical significance of his legacy. His work in defense of people with mental disorders represents his fight for the protection of human dignity and the value of life. Pejoratively called “the philosopher Basaglia,” he transformed psychiatric practices by pushing the boundaries of medicine to address profound human rights issues. Basaglia adopted an existential-analytical stance that underpinned his commitment to psychiatric reform and the management of mental health practice, inspiring changes in public policies around the world. This commemorative editorial presents a historical overview of Franco Basaglia's contributions to psychiatric reform and their implications for mental health care.
Background Since the late 19th century and over the last decades, executive functions (EF) have received increasing attentionin neuropsychology and clinical psychology for their influence on various domains of functioning, activities of daily living, and various psychological and mental disorders. Methods In this commentary, we aim to describe the major theoretical models of EF, their structures, clinical implications, with a focus on some neurodevelopmental disorders and major neurocognitive disorders. Results Two main approaches emerge: unitary models ( e.g. , Stuss and Benson, Norman and Shallice, Lezak) view EF as an integrated self-regulatory system, while multi-component models ( e.g ., Miyake, Diamond, Zelazo) describe separable but interconnected processes such as inhibition, working memory, and cognitive flexibility. In individuals with some neurodevelopmental disorders and major neurocognitive disorders, EF may be impaired (while sometimes only some EFs are affected, in other situations, all EFs are negatively influenced). Discussion Contemporary EF theoretical models integrate unitary and multi-component perspectives. They describe EF as coordinated yet distinguishable control processes. Looking at some clinical conditions, such as neurodevelopmental disorders and major neurocognitive disorders, both unitary and multi-component perspectives are supported: in some specific clinical conditions, specific processes and/or modules of EF may be selectively impaired. There is still an open debate on the role of EF as a transdiagnostic feature. Conclusion Executive functions represent a fundamental domain for understanding adaptive behaviour across the lifespan. Future research should further clarify the relationships among executive subcomponents, their neural mechanisms, and their role across psychological and neurological disorders, thereby contributing to more refined theoretical models and more targeted clinical assessment and rehabilitation strategies, as well as their role as a transdiagnostic construct.
Introduction Virtual reality (VR) is a promising tool for diagnosis and therapy in Panic Disorder (PD), allowing controlled exposure to anxiety-provoking situations and real-time assessment of behaviors and physiological responses. Studies indicate its effectiveness in reducing symptoms and its therapeutic applicability. However, there is a lack of robust data on its specific impact on heart rate variability (HRV), sense of presence, safety, and acceptability in patients with PD and agoraphobia. Therefore, further research is warranted to evaluate these aspects, aiming for a broader understanding and optimization of this technology in mental health. Objective Thus, this experimental crossover study protocol aims to evaluate the sense of presence, method safety, acceptability, psychological ( i.e. , anxiety), and physiological changes ( i.e. , respiratory and heart rate, HRV, tidal volume and respiratory minute volume, and level of skin conductance). In addition, correlate the psychological measures with the physiological ones. Methodology This is an experimental crossover study protocol, following an within-subject crossover design, with independent groups (between-subjects), in which 25 PD patients and 25 controls will be randomly allocated, through block randomization to an experimental group (PD patients) and a control group (healthy individuals) where they will go through the following sequences: (1) initial exposure to 2D video, using projection glasses, followed by the same scene in VR with the Oculus 2 headset; or (2) initial exposure in VR, followed by the 2D video. VR offers an ecological and multimodal method for assessment, aligned with initiatives such as RDoC. The protocol, structured in modules that reflect components of Cognitive-Behavioral Therapy, aims to test the system's ability to respond to clinically relevant anxiety in a safe and acceptable manner. Results The results of the trial will be published in international peer-reviewed journals and will be disseminated at international meetings and congresses. Discussion Potential contributions include a more objective and standardized assessment, useful for personalizing interventions. Limitations such as sample size and ecological validity are acknowledged. Conclusion In conclusion, the protocol represents a methodological advancement. The results of this predictive study will be crucial for refining the technology and informing future clinical trials, with the potential to improve diagnostic accuracy and optimize personalized therapeutic strategies for PD.